Compare CHI & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHI | SPTX |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 933.6M |
| IPO Year | 2002 | 2026 |
| Metric | CHI | SPTX |
|---|---|---|
| Price | $13.19 | N/A |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 149.1K | N/A |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | ★ 9.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.10 | N/A |
| 52 Week High | $13.22 | N/A |
| Indicator | CHI | SPTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | N/A |
| Support Level | $10.40 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.23 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 98.87 | 0.00 |
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.